We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFC
2201
DELISTED
Premier Financial Corp. Common Stock
PFC
| $636K | ﹤0.01% |
24,244
+140
| +0.6% | +$3.53K |
|
2202
TG Therapeutics
TGTX
$7.96B
| $632K | ﹤0.01% |
53,292
+690
| +1% | +$7.86K |
|
|
NEWS
2203
DELISTED
NewStar Financial, Inc.
NEWS
| $625K | ﹤0.01% |
53,240
+445
| +0.8% | +$4.86K |
|
2204
Lexicon Pharmaceuticals
LXRX
$1.03B
| $624K | ﹤0.01% |
50,791
+1,260
| +3% | +$18.6K |
|
|
BELFB
2205
Bel Fuse Inc Class B
BELFB
$3.87B
| $623K | ﹤0.01% |
19,958
+1,005
| +5% | +$26.5K |
|
2206
HCI Group
HCI
$2.23B
| $623K | ﹤0.01% |
16,283
+493
| +3% | +$20.2K |
|
|
INWK
2207
DELISTED
InnerWorkings, Inc.
INWK
| $623K | ﹤0.01% |
55,391
+585
| +1% | +$6.48K |
|
2208
Kinsale Capital Group
KNSL
$8.12B
| $622K | ﹤0.01% |
14,418
+414
| +3% | +$16.1K |
|
2209
Aclaris Therapeutics
ACRS
$726M
| $621K | ﹤0.01% |
24,048
+1,095
| +5% | +$29.3K |
|
2210
Westwood Holdings Group
WHG
$182M
| $620K | ﹤0.01% |
9,217
+140
| +2% | +$8.37K |
|
2211
QCR Holdings
QCRH
$1.69B
| $618K | ﹤0.01% |
13,588
+110
| +0.8% | +$4.96K |
|
2212
Kforce
KFRC
$1.02B
| $613K | ﹤0.01% |
30,329
-602
| -2% | -$11.2K |
|
2213
KRONOS Worldwide
KRO
$693M
| $610K | ﹤0.01% |
26,711
+325
| +1% | +$6.68K |
|
|
ICON
2214
DELISTED
Iconix Brand Group, Inc.
ICON
| $609K | ﹤0.01% |
10,702
+267
| +3% | +$15.9K |
|
|
NEX
2215
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $608K | ﹤0.01% |
36,440
+182
| +0.5% | +$2.67K |
|
|
DSPG
2216
DELISTED
DSP Group Inc
DSPG
| $606K | ﹤0.01% |
46,631
+950
| +2% | +$11.5K |
|
|
CARB
2217
DELISTED
Carbonite Inc
CARB
| $606K | ﹤0.01% |
27,533
+370
| +1% | +$7.83K |
|
2218
Teekay
TK
$1.01B
| $605K | ﹤0.01% |
67,794
+390
| +0.6% | +$3.41K |
|
|
OKSB
2219
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $603K | ﹤0.01% |
21,900
-485
| -2% | -$12.5K |
|
2220
First Community Bankshares
FCBC
$900M
| $602K | ﹤0.01% |
20,670
+200
| +1% | +$5.35K |
|
2221
CytomX Therapeutics
CTMX
$675M
| $600K | ﹤0.01% |
32,997
+480
| +1% | +$7.49K |
|
|
BBBY
2222
Bed Bath & Beyond
BBBY
$481M
| $599K | ﹤0.01% |
26,852
+240
| +0.9% | +$3.62K |
|
2223
Triumph Financial Inc
TFIN
$1.81B
| $599K | ﹤0.01% |
18,571
+865
| +5% | +$24.3K |
|
|
UCFC
2224
DELISTED
United Community Financial Corp
UCFC
| $598K | ﹤0.01% |
62,301
+290
| +0.5% | +$2.61K |
|
2225
Waterstone Financial
WSBF
$370M
| $596K | ﹤0.01% |
30,549
+235
| +0.8% | +$4.33K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.